Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 3
2016 4
2017 2
2018 3
2019 2
2020 3
2021 5
2022 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem V, Günthard HF, Zangerle R, Smith C, Castagna A, d'Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group. Álvarez H, et al. Clin Infect Dis. 2023 Aug 22;77(4):593-605. doi: 10.1093/cid/ciad219. Clin Infect Dis. 2023. PMID: 37052343 Free PMC article.
Not Recommended, But Done: Breastfeeding with HIV in Germany.
Haberl L, Audebert F, Feiterna-Sperling C, Gillor D, Jakubowski P, Jonsson-Oldenbüttel C, Khaykin P, Kiener R, Reitter A, Rieke A, Rodríguez E, Rößler S, Rump JA, Schüttfort G, Stephan C, Ulmer A, von Braun A, von Weizsäcker K, Haberl A. Haberl L, et al. Among authors: schuttfort g. AIDS Patient Care STDS. 2021 Feb;35(2):33-38. doi: 10.1089/apc.2020.0223. AIDS Patient Care STDS. 2021. PMID: 33571048
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Clinical Trial.
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
Chammartin F, Mocroft A, Egle A, Zangerle R, Smith C, Mussini C, Wit F, Vehreschild JJ, d'Arminio Monforte A, Castagna A, Bailly L, Bogner J, de Wit S, Matulionyte R, Law M, Svedhem V, Tallada J, Garges HP, Marongiu A, Borges ÁH, Jaschinski N, Neesgaard B, Ryom L, Bucher HC; RESPOND Study Group. Chammartin F, et al. Clin Infect Dis. 2024 Apr 10;78(4):995-1004. doi: 10.1093/cid/ciad671. Clin Infect Dis. 2024. PMID: 38092042 Free PMC article.
Influence of tenofovir exposure in utero on primary dentition.
Schüttfort G, Höfler S, Kann G, Königs C, de Leuw P, Herrmann E, Stephan C, Haberl A. Schüttfort G, et al. Eur J Pediatr. 2020 Nov;179(11):1761-1768. doi: 10.1007/s00431-020-03660-1. Epub 2020 May 19. Eur J Pediatr. 2020. PMID: 32424746
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting.
Greenberg L, Ryom L, Neesgaard B, Miró JM, Dahlerup Rasmussen L, Zangerle R, Grabmeier-Pfistershammer K, Günthard HF, Kusejko K, Smith C, Mussini C, Menozzi M, Wit F, Van Der Valk M, d'Arminio Monforte A, De Wit S, Necsoi C, Pelchen-Matthews A, Lundgren J, Peters L, Castagna A, Muccini C, Vehreschild JJ, Pradier C, Bruguera Riera A, Sönnerborg A, Petoumenos K, Garges H, Rogatto F, Dedes N, Bansi-Matharu L, Mocroft A; RESPOND Study Group. Greenberg L, et al. Open Forum Infect Dis. 2022 Jan 19;9(3):ofac029. doi: 10.1093/ofid/ofac029. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35198646 Free PMC article.
High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysis.
Wetzstein N, Kessel J, Bingold TM, Carney J, Graf C, Koch BF, Meier F, Baumgarten J, Küpper-Tetzel CP, Khodamoradi Y, Wolf T, Schüttfort G, Vehreschild MJGT, Wichelhaus TA, Stephan C. Wetzstein N, et al. Among authors: schuttfort g. J Infect. 2022 Jan;84(1):8-16. doi: 10.1016/j.jinf.2021.10.027. Epub 2021 Nov 14. J Infect. 2022. PMID: 34788633
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study.
Wetzstein N, Geil A, Kann G, Lehn A, Schüttfort G, Kessel J, Bingold TM, Küpper-Tetzel CP, Haberl A, Graf C, Vehreschild MJGT, Stephan C, Hogardt M, Wichelhaus TA, Wolf T. Wetzstein N, et al. Among authors: schuttfort g. PLoS One. 2021 Jul 13;16(7):e0254607. doi: 10.1371/journal.pone.0254607. eCollection 2021. PLoS One. 2021. PMID: 34255788 Free PMC article.
28 results